Global Clinical Next Generation Sequencing (NGS) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Clinical Next Generation Sequencing (NGS) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Clinical Next Generation Sequencing (NGS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Clinical Next Generation Sequencing (NGS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Clinical Next Generation Sequencing (NGS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Clinical Next Generation Sequencing (NGS) players cover Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, Bio-Rad and Congenica, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Clinical Next Generation Sequencing (NGS) Industry Forecast” looks at past sales and reviews total world Clinical Next Generation Sequencing (NGS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Next Generation Sequencing (NGS) sales for 2023 through 2029. With Clinical Next Generation Sequencing (NGS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Next Generation Sequencing (NGS) industry.
This Insight Report provides a comprehensive analysis of the global Clinical Next Generation Sequencing (NGS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Next Generation Sequencing (NGS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Next Generation Sequencing (NGS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Next Generation Sequencing (NGS) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Next Generation Sequencing (NGS).
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Next Generation Sequencing (NGS) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Clinical Next Generation Sequencing (NGS) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Clinical Next Generation Sequencing (NGS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Clinical Next Generation Sequencing (NGS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Clinical Next Generation Sequencing (NGS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Clinical Next Generation Sequencing (NGS) players cover Agilent Technologies, Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, Bio-Rad and Congenica, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Clinical Next Generation Sequencing (NGS) Industry Forecast” looks at past sales and reviews total world Clinical Next Generation Sequencing (NGS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Next Generation Sequencing (NGS) sales for 2023 through 2029. With Clinical Next Generation Sequencing (NGS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Next Generation Sequencing (NGS) industry.
This Insight Report provides a comprehensive analysis of the global Clinical Next Generation Sequencing (NGS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Next Generation Sequencing (NGS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Next Generation Sequencing (NGS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Next Generation Sequencing (NGS) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Next Generation Sequencing (NGS).
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Next Generation Sequencing (NGS) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Sequencing by Synthesis (SBS)
- Nanopore Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Others
- Diagnostics
- Drug Discovery & Designing
- Medical Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Agilent Technologies
- Illumina
- Thermo Fisher Scientific
- Eurofins Scientific
- BGI Group
- Qiagen
- Roche Diagnostics
- Bio-Rad
- Congenica
- Theragen Etex
- PerkinElmer
- Partek
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- Golden Helix
- BioDatomics
- PierianDx
- DNAStar
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Clinical Next Generation Sequencing (NGS) Market Size 2018-2029
2.1.2 Clinical Next Generation Sequencing (NGS) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Clinical Next Generation Sequencing (NGS) Segment by Type
2.2.1 Sequencing by Synthesis (SBS)
2.2.2 Nanopore Sequencing
2.2.3 Single-Molecule Real-Time (SMRT) Sequencing
2.2.4 Others
2.3 Clinical Next Generation Sequencing (NGS) Market Size by Type
2.3.1 Clinical Next Generation Sequencing (NGS) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
2.4 Clinical Next Generation Sequencing (NGS) Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery & Designing
2.4.3 Medical Research
2.4.4 Others
2.5 Clinical Next Generation Sequencing (NGS) Market Size by Application
2.5.1 Clinical Next Generation Sequencing (NGS) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
3 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE BY PLAYER
3.1 Clinical Next Generation Sequencing (NGS) Market Size Market Share by Players
3.1.1 Global Clinical Next Generation Sequencing (NGS) Revenue by Players (2018-2023)
3.1.2 Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Next Generation Sequencing (NGS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CLINICAL NEXT GENERATION SEQUENCING (NGS) BY REGIONS
4.1 Clinical Next Generation Sequencing (NGS) Market Size by Regions (2018-2023)
4.2 Americas Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
4.3 APAC Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
4.4 Europe Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
4.5 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
5.2 Americas Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
5.3 Americas Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023)
6.2 APAC Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
6.3 APAC Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Clinical Next Generation Sequencing (NGS) by Country (2018-2023)
7.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
7.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) by Region (2018-2023)
8.2 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
8.3 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST
10.1 Global Clinical Next Generation Sequencing (NGS) Forecast by Regions (2024-2029)
10.1.1 Global Clinical Next Generation Sequencing (NGS) Forecast by Regions (2024-2029)
10.1.2 Americas Clinical Next Generation Sequencing (NGS) Forecast
10.1.3 APAC Clinical Next Generation Sequencing (NGS) Forecast
10.1.4 Europe Clinical Next Generation Sequencing (NGS) Forecast
10.1.5 Middle East & Africa Clinical Next Generation Sequencing (NGS) Forecast
10.2 Americas Clinical Next Generation Sequencing (NGS) Forecast by Country (2024-2029)
10.2.1 United States Clinical Next Generation Sequencing (NGS) Market Forecast
10.2.2 Canada Clinical Next Generation Sequencing (NGS) Market Forecast
10.2.3 Mexico Clinical Next Generation Sequencing (NGS) Market Forecast
10.2.4 Brazil Clinical Next Generation Sequencing (NGS) Market Forecast
10.3 APAC Clinical Next Generation Sequencing (NGS) Forecast by Region (2024-2029)
10.3.1 China Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.2 Japan Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.3 Korea Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.4 Southeast Asia Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.5 India Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.6 Australia Clinical Next Generation Sequencing (NGS) Market Forecast
10.4 Europe Clinical Next Generation Sequencing (NGS) Forecast by Country (2024-2029)
10.4.1 Germany Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.2 France Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.3 UK Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.4 Italy Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.5 Russia Clinical Next Generation Sequencing (NGS) Market Forecast
10.5 Middle East & Africa Clinical Next Generation Sequencing (NGS) Forecast by Region (2024-2029)
10.5.1 Egypt Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.2 South Africa Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.3 Israel Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.4 Turkey Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.5 GCC Countries Clinical Next Generation Sequencing (NGS) Market Forecast
10.6 Global Clinical Next Generation Sequencing (NGS) Forecast by Type (2024-2029)
10.7 Global Clinical Next Generation Sequencing (NGS) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Offered
11.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Clinical Next Generation Sequencing (NGS) Product Offered
11.2.3 Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Offered
11.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Offered
11.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 BGI Group
11.5.1 BGI Group Company Information
11.5.2 BGI Group Clinical Next Generation Sequencing (NGS) Product Offered
11.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BGI Group Main Business Overview
11.5.5 BGI Group Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen Clinical Next Generation Sequencing (NGS) Product Offered
11.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Information
11.7.2 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Offered
11.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Roche Diagnostics Main Business Overview
11.7.5 Roche Diagnostics Latest Developments
11.8 Bio-Rad
11.8.1 Bio-Rad Company Information
11.8.2 Bio-Rad Clinical Next Generation Sequencing (NGS) Product Offered
11.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bio-Rad Main Business Overview
11.8.5 Bio-Rad Latest Developments
11.9 Congenica
11.9.1 Congenica Company Information
11.9.2 Congenica Clinical Next Generation Sequencing (NGS) Product Offered
11.9.3 Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Congenica Main Business Overview
11.9.5 Congenica Latest Developments
11.10 Theragen Etex
11.10.1 Theragen Etex Company Information
11.10.2 Theragen Etex Clinical Next Generation Sequencing (NGS) Product Offered
11.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Theragen Etex Main Business Overview
11.10.5 Theragen Etex Latest Developments
11.11 PerkinElmer
11.11.1 PerkinElmer Company Information
11.11.2 PerkinElmer Clinical Next Generation Sequencing (NGS) Product Offered
11.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 PerkinElmer Main Business Overview
11.11.5 PerkinElmer Latest Developments
11.12 Partek
11.12.1 Partek Company Information
11.12.2 Partek Clinical Next Generation Sequencing (NGS) Product Offered
11.12.3 Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Partek Main Business Overview
11.12.5 Partek Latest Developments
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Information
11.13.2 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Offered
11.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Oxford Nanopore Technologies Main Business Overview
11.13.5 Oxford Nanopore Technologies Latest Developments
11.14 Pacific Biosciences of California
11.14.1 Pacific Biosciences of California Company Information
11.14.2 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Offered
11.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Pacific Biosciences of California Main Business Overview
11.14.5 Pacific Biosciences of California Latest Developments
11.15 Golden Helix
11.15.1 Golden Helix Company Information
11.15.2 Golden Helix Clinical Next Generation Sequencing (NGS) Product Offered
11.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Golden Helix Main Business Overview
11.15.5 Golden Helix Latest Developments
11.16 BioDatomics
11.16.1 BioDatomics Company Information
11.16.2 BioDatomics Clinical Next Generation Sequencing (NGS) Product Offered
11.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BioDatomics Main Business Overview
11.16.5 BioDatomics Latest Developments
11.17 PierianDx
11.17.1 PierianDx Company Information
11.17.2 PierianDx Clinical Next Generation Sequencing (NGS) Product Offered
11.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 PierianDx Main Business Overview
11.17.5 PierianDx Latest Developments
11.18 DNAStar
11.18.1 DNAStar Company Information
11.18.2 DNAStar Clinical Next Generation Sequencing (NGS) Product Offered
11.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 DNAStar Main Business Overview
11.18.5 DNAStar Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Clinical Next Generation Sequencing (NGS) Market Size 2018-2029
2.1.2 Clinical Next Generation Sequencing (NGS) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Clinical Next Generation Sequencing (NGS) Segment by Type
2.2.1 Sequencing by Synthesis (SBS)
2.2.2 Nanopore Sequencing
2.2.3 Single-Molecule Real-Time (SMRT) Sequencing
2.2.4 Others
2.3 Clinical Next Generation Sequencing (NGS) Market Size by Type
2.3.1 Clinical Next Generation Sequencing (NGS) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
2.4 Clinical Next Generation Sequencing (NGS) Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery & Designing
2.4.3 Medical Research
2.4.4 Others
2.5 Clinical Next Generation Sequencing (NGS) Market Size by Application
2.5.1 Clinical Next Generation Sequencing (NGS) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
3 CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE BY PLAYER
3.1 Clinical Next Generation Sequencing (NGS) Market Size Market Share by Players
3.1.1 Global Clinical Next Generation Sequencing (NGS) Revenue by Players (2018-2023)
3.1.2 Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Next Generation Sequencing (NGS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CLINICAL NEXT GENERATION SEQUENCING (NGS) BY REGIONS
4.1 Clinical Next Generation Sequencing (NGS) Market Size by Regions (2018-2023)
4.2 Americas Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
4.3 APAC Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
4.4 Europe Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
4.5 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023)
5.2 Americas Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
5.3 Americas Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023)
6.2 APAC Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
6.3 APAC Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Clinical Next Generation Sequencing (NGS) by Country (2018-2023)
7.2 Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
7.3 Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Clinical Next Generation Sequencing (NGS) by Region (2018-2023)
8.2 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023)
8.3 Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CLINICAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST
10.1 Global Clinical Next Generation Sequencing (NGS) Forecast by Regions (2024-2029)
10.1.1 Global Clinical Next Generation Sequencing (NGS) Forecast by Regions (2024-2029)
10.1.2 Americas Clinical Next Generation Sequencing (NGS) Forecast
10.1.3 APAC Clinical Next Generation Sequencing (NGS) Forecast
10.1.4 Europe Clinical Next Generation Sequencing (NGS) Forecast
10.1.5 Middle East & Africa Clinical Next Generation Sequencing (NGS) Forecast
10.2 Americas Clinical Next Generation Sequencing (NGS) Forecast by Country (2024-2029)
10.2.1 United States Clinical Next Generation Sequencing (NGS) Market Forecast
10.2.2 Canada Clinical Next Generation Sequencing (NGS) Market Forecast
10.2.3 Mexico Clinical Next Generation Sequencing (NGS) Market Forecast
10.2.4 Brazil Clinical Next Generation Sequencing (NGS) Market Forecast
10.3 APAC Clinical Next Generation Sequencing (NGS) Forecast by Region (2024-2029)
10.3.1 China Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.2 Japan Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.3 Korea Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.4 Southeast Asia Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.5 India Clinical Next Generation Sequencing (NGS) Market Forecast
10.3.6 Australia Clinical Next Generation Sequencing (NGS) Market Forecast
10.4 Europe Clinical Next Generation Sequencing (NGS) Forecast by Country (2024-2029)
10.4.1 Germany Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.2 France Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.3 UK Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.4 Italy Clinical Next Generation Sequencing (NGS) Market Forecast
10.4.5 Russia Clinical Next Generation Sequencing (NGS) Market Forecast
10.5 Middle East & Africa Clinical Next Generation Sequencing (NGS) Forecast by Region (2024-2029)
10.5.1 Egypt Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.2 South Africa Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.3 Israel Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.4 Turkey Clinical Next Generation Sequencing (NGS) Market Forecast
10.5.5 GCC Countries Clinical Next Generation Sequencing (NGS) Market Forecast
10.6 Global Clinical Next Generation Sequencing (NGS) Forecast by Type (2024-2029)
10.7 Global Clinical Next Generation Sequencing (NGS) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Offered
11.1.3 Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Clinical Next Generation Sequencing (NGS) Product Offered
11.2.3 Illumina Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Offered
11.3.3 Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Offered
11.4.3 Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 BGI Group
11.5.1 BGI Group Company Information
11.5.2 BGI Group Clinical Next Generation Sequencing (NGS) Product Offered
11.5.3 BGI Group Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BGI Group Main Business Overview
11.5.5 BGI Group Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen Clinical Next Generation Sequencing (NGS) Product Offered
11.6.3 Qiagen Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 Roche Diagnostics
11.7.1 Roche Diagnostics Company Information
11.7.2 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Offered
11.7.3 Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Roche Diagnostics Main Business Overview
11.7.5 Roche Diagnostics Latest Developments
11.8 Bio-Rad
11.8.1 Bio-Rad Company Information
11.8.2 Bio-Rad Clinical Next Generation Sequencing (NGS) Product Offered
11.8.3 Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Bio-Rad Main Business Overview
11.8.5 Bio-Rad Latest Developments
11.9 Congenica
11.9.1 Congenica Company Information
11.9.2 Congenica Clinical Next Generation Sequencing (NGS) Product Offered
11.9.3 Congenica Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Congenica Main Business Overview
11.9.5 Congenica Latest Developments
11.10 Theragen Etex
11.10.1 Theragen Etex Company Information
11.10.2 Theragen Etex Clinical Next Generation Sequencing (NGS) Product Offered
11.10.3 Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Theragen Etex Main Business Overview
11.10.5 Theragen Etex Latest Developments
11.11 PerkinElmer
11.11.1 PerkinElmer Company Information
11.11.2 PerkinElmer Clinical Next Generation Sequencing (NGS) Product Offered
11.11.3 PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 PerkinElmer Main Business Overview
11.11.5 PerkinElmer Latest Developments
11.12 Partek
11.12.1 Partek Company Information
11.12.2 Partek Clinical Next Generation Sequencing (NGS) Product Offered
11.12.3 Partek Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Partek Main Business Overview
11.12.5 Partek Latest Developments
11.13 Oxford Nanopore Technologies
11.13.1 Oxford Nanopore Technologies Company Information
11.13.2 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Offered
11.13.3 Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Oxford Nanopore Technologies Main Business Overview
11.13.5 Oxford Nanopore Technologies Latest Developments
11.14 Pacific Biosciences of California
11.14.1 Pacific Biosciences of California Company Information
11.14.2 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Offered
11.14.3 Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Pacific Biosciences of California Main Business Overview
11.14.5 Pacific Biosciences of California Latest Developments
11.15 Golden Helix
11.15.1 Golden Helix Company Information
11.15.2 Golden Helix Clinical Next Generation Sequencing (NGS) Product Offered
11.15.3 Golden Helix Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Golden Helix Main Business Overview
11.15.5 Golden Helix Latest Developments
11.16 BioDatomics
11.16.1 BioDatomics Company Information
11.16.2 BioDatomics Clinical Next Generation Sequencing (NGS) Product Offered
11.16.3 BioDatomics Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BioDatomics Main Business Overview
11.16.5 BioDatomics Latest Developments
11.17 PierianDx
11.17.1 PierianDx Company Information
11.17.2 PierianDx Clinical Next Generation Sequencing (NGS) Product Offered
11.17.3 PierianDx Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 PierianDx Main Business Overview
11.17.5 PierianDx Latest Developments
11.18 DNAStar
11.18.1 DNAStar Company Information
11.18.2 DNAStar Clinical Next Generation Sequencing (NGS) Product Offered
11.18.3 DNAStar Clinical Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 DNAStar Main Business Overview
11.18.5 DNAStar Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Clinical Next Generation Sequencing (NGS) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Sequencing by Synthesis (SBS)
Table 3. Major Players of Nanopore Sequencing
Table 4. Major Players of Single-Molecule Real-Time (SMRT) Sequencing
Table 5. Major Players of Others
Table 6. Clinical Next Generation Sequencing (NGS) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 9. Clinical Next Generation Sequencing (NGS) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 12. Global Clinical Next Generation Sequencing (NGS) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Player (2018-2023)
Table 14. Clinical Next Generation Sequencing (NGS) Key Players Head office and Products Offered
Table 15. Clinical Next Generation Sequencing (NGS) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Clinical Next Generation Sequencing (NGS) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Regions (2018-2023)
Table 20. Global Clinical Next Generation Sequencing (NGS) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Clinical Next Generation Sequencing (NGS) Market Size Market Share by Country (2018-2023)
Table 24. Americas Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 26. Americas Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 28. APAC Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region (2018-2023)
Table 30. APAC Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 32. APAC Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 34. Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Country (2018-2023)
Table 36. Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 38. Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Clinical Next Generation Sequencing (NGS)
Table 47. Key Market Challenges & Risks of Clinical Next Generation Sequencing (NGS)
Table 48. Key Industry Trends of Clinical Next Generation Sequencing (NGS)
Table 49. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Agilent Technologies Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 54. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Offered
Table 55. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Agilent Technologies Main Business
Table 57. Agilent Technologies Latest Developments
Table 58. Illumina Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 59. Illumina Clinical Next Generation Sequencing (NGS) Product Offered
Table 60. Illumina Main Business
Table 61. Illumina Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Illumina Latest Developments
Table 63. Thermo Fisher Scientific Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Offered
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. Eurofins Scientific Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 69. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Offered
Table 70. Eurofins Scientific Main Business
Table 71. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Eurofins Scientific Latest Developments
Table 73. BGI Group Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 74. BGI Group Clinical Next Generation Sequencing (NGS) Product Offered
Table 75. BGI Group Main Business
Table 76. BGI Group Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. BGI Group Latest Developments
Table 78. Qiagen Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 79. Qiagen Clinical Next Generation Sequencing (NGS) Product Offered
Table 80. Qiagen Main Business
Table 81. Qiagen Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Qiagen Latest Developments
Table 83. Roche Diagnostics Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 84. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Offered
Table 85. Roche Diagnostics Main Business
Table 86. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Roche Diagnostics Latest Developments
Table 88. Bio-Rad Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 89. Bio-Rad Clinical Next Generation Sequencing (NGS) Product Offered
Table 90. Bio-Rad Main Business
Table 91. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Bio-Rad Latest Developments
Table 93. Congenica Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 94. Congenica Clinical Next Generation Sequencing (NGS) Product Offered
Table 95. Congenica Main Business
Table 96. Congenica Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Congenica Latest Developments
Table 98. Theragen Etex Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 99. Theragen Etex Clinical Next Generation Sequencing (NGS) Product Offered
Table 100. Theragen Etex Main Business
Table 101. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Theragen Etex Latest Developments
Table 103. PerkinElmer Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 104. PerkinElmer Clinical Next Generation Sequencing (NGS) Product Offered
Table 105. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. PerkinElmer Main Business
Table 107. PerkinElmer Latest Developments
Table 108. Partek Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 109. Partek Clinical Next Generation Sequencing (NGS) Product Offered
Table 110. Partek Main Business
Table 111. Partek Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Partek Latest Developments
Table 113. Oxford Nanopore Technologies Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 114. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Offered
Table 115. Oxford Nanopore Technologies Main Business
Table 116. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Oxford Nanopore Technologies Latest Developments
Table 118. Pacific Biosciences of California Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 119. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Offered
Table 120. Pacific Biosciences of California Main Business
Table 121. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Pacific Biosciences of California Latest Developments
Table 123. Golden Helix Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 124. Golden Helix Clinical Next Generation Sequencing (NGS) Product Offered
Table 125. Golden Helix Main Business
Table 126. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Golden Helix Latest Developments
Table 128. BioDatomics Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 129. BioDatomics Clinical Next Generation Sequencing (NGS) Product Offered
Table 130. BioDatomics Main Business
Table 131. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. BioDatomics Latest Developments
Table 133. PierianDx Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 134. PierianDx Clinical Next Generation Sequencing (NGS) Product Offered
Table 135. PierianDx Main Business
Table 136. PierianDx Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. PierianDx Latest Developments
Table 138. DNAStar Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 139. DNAStar Clinical Next Generation Sequencing (NGS) Product Offered
Table 140. DNAStar Main Business
Table 141. DNAStar Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. DNAStar Latest Developments
Table 1. Clinical Next Generation Sequencing (NGS) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Sequencing by Synthesis (SBS)
Table 3. Major Players of Nanopore Sequencing
Table 4. Major Players of Single-Molecule Real-Time (SMRT) Sequencing
Table 5. Major Players of Others
Table 6. Clinical Next Generation Sequencing (NGS) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 9. Clinical Next Generation Sequencing (NGS) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 12. Global Clinical Next Generation Sequencing (NGS) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Player (2018-2023)
Table 14. Clinical Next Generation Sequencing (NGS) Key Players Head office and Products Offered
Table 15. Clinical Next Generation Sequencing (NGS) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Clinical Next Generation Sequencing (NGS) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Regions (2018-2023)
Table 20. Global Clinical Next Generation Sequencing (NGS) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Clinical Next Generation Sequencing (NGS) Market Size Market Share by Country (2018-2023)
Table 24. Americas Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 26. Americas Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 28. APAC Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region (2018-2023)
Table 30. APAC Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 32. APAC Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 34. Europe Clinical Next Generation Sequencing (NGS) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Country (2018-2023)
Table 36. Europe Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 38. Europe Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Clinical Next Generation Sequencing (NGS)
Table 47. Key Market Challenges & Risks of Clinical Next Generation Sequencing (NGS)
Table 48. Key Industry Trends of Clinical Next Generation Sequencing (NGS)
Table 49. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Clinical Next Generation Sequencing (NGS) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Agilent Technologies Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 54. Agilent Technologies Clinical Next Generation Sequencing (NGS) Product Offered
Table 55. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Agilent Technologies Main Business
Table 57. Agilent Technologies Latest Developments
Table 58. Illumina Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 59. Illumina Clinical Next Generation Sequencing (NGS) Product Offered
Table 60. Illumina Main Business
Table 61. Illumina Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Illumina Latest Developments
Table 63. Thermo Fisher Scientific Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Product Offered
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. Eurofins Scientific Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 69. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Product Offered
Table 70. Eurofins Scientific Main Business
Table 71. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Eurofins Scientific Latest Developments
Table 73. BGI Group Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 74. BGI Group Clinical Next Generation Sequencing (NGS) Product Offered
Table 75. BGI Group Main Business
Table 76. BGI Group Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. BGI Group Latest Developments
Table 78. Qiagen Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 79. Qiagen Clinical Next Generation Sequencing (NGS) Product Offered
Table 80. Qiagen Main Business
Table 81. Qiagen Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Qiagen Latest Developments
Table 83. Roche Diagnostics Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 84. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Product Offered
Table 85. Roche Diagnostics Main Business
Table 86. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Roche Diagnostics Latest Developments
Table 88. Bio-Rad Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 89. Bio-Rad Clinical Next Generation Sequencing (NGS) Product Offered
Table 90. Bio-Rad Main Business
Table 91. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Bio-Rad Latest Developments
Table 93. Congenica Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 94. Congenica Clinical Next Generation Sequencing (NGS) Product Offered
Table 95. Congenica Main Business
Table 96. Congenica Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Congenica Latest Developments
Table 98. Theragen Etex Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 99. Theragen Etex Clinical Next Generation Sequencing (NGS) Product Offered
Table 100. Theragen Etex Main Business
Table 101. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Theragen Etex Latest Developments
Table 103. PerkinElmer Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 104. PerkinElmer Clinical Next Generation Sequencing (NGS) Product Offered
Table 105. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. PerkinElmer Main Business
Table 107. PerkinElmer Latest Developments
Table 108. Partek Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 109. Partek Clinical Next Generation Sequencing (NGS) Product Offered
Table 110. Partek Main Business
Table 111. Partek Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Partek Latest Developments
Table 113. Oxford Nanopore Technologies Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 114. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Product Offered
Table 115. Oxford Nanopore Technologies Main Business
Table 116. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Oxford Nanopore Technologies Latest Developments
Table 118. Pacific Biosciences of California Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 119. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Product Offered
Table 120. Pacific Biosciences of California Main Business
Table 121. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Pacific Biosciences of California Latest Developments
Table 123. Golden Helix Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 124. Golden Helix Clinical Next Generation Sequencing (NGS) Product Offered
Table 125. Golden Helix Main Business
Table 126. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Golden Helix Latest Developments
Table 128. BioDatomics Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 129. BioDatomics Clinical Next Generation Sequencing (NGS) Product Offered
Table 130. BioDatomics Main Business
Table 131. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. BioDatomics Latest Developments
Table 133. PierianDx Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 134. PierianDx Clinical Next Generation Sequencing (NGS) Product Offered
Table 135. PierianDx Main Business
Table 136. PierianDx Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. PierianDx Latest Developments
Table 138. DNAStar Details, Company Type, Clinical Next Generation Sequencing (NGS) Area Served and Its Competitors
Table 139. DNAStar Clinical Next Generation Sequencing (NGS) Product Offered
Table 140. DNAStar Main Business
Table 141. DNAStar Clinical Next Generation Sequencing (NGS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. DNAStar Latest Developments
LIST OF FIGURES
Figure 1. Clinical Next Generation Sequencing (NGS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Clinical Next Generation Sequencing (NGS) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Clinical Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2022)
Figure 8. Clinical Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type in 2022
Figure 10. Clinical Next Generation Sequencing (NGS) in Diagnostics
Figure 11. Global Clinical Next Generation Sequencing (NGS) Market: Diagnostics (2018-2023) & ($ Millions)
Figure 12. Clinical Next Generation Sequencing (NGS) in Drug Discovery & Designing
Figure 13. Global Clinical Next Generation Sequencing (NGS) Market: Drug Discovery & Designing (2018-2023) & ($ Millions)
Figure 14. Clinical Next Generation Sequencing (NGS) in Medical Research
Figure 15. Global Clinical Next Generation Sequencing (NGS) Market: Medical Research (2018-2023) & ($ Millions)
Figure 16. Clinical Next Generation Sequencing (NGS) in Others
Figure 17. Global Clinical Next Generation Sequencing (NGS) Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application in 2022
Figure 19. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Player in 2022
Figure 20. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 22. APAC Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 23. Europe Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 25. Americas Clinical Next Generation Sequencing (NGS) Value Market Share by Country in 2022
Figure 26. United States Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region in 2022
Figure 31. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type in 2022
Figure 32. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application in 2022
Figure 33. China Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Country in 2022
Figure 40. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Figure 41. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Figure 42. Germany Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 56. APAC Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 57. Europe Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 59. United States Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 60. Canada Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 63. China Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 64. Japan Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 65. Korea Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 67. India Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 68. Australia Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 69. Germany Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 70. France Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 71. UK Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 72. Italy Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 73. Russia Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 74. Spain Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 77. Israel Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 80. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Clinical Next Generation Sequencing (NGS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Clinical Next Generation Sequencing (NGS) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Clinical Next Generation Sequencing (NGS) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Clinical Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2022)
Figure 8. Clinical Next Generation Sequencing (NGS) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type in 2022
Figure 10. Clinical Next Generation Sequencing (NGS) in Diagnostics
Figure 11. Global Clinical Next Generation Sequencing (NGS) Market: Diagnostics (2018-2023) & ($ Millions)
Figure 12. Clinical Next Generation Sequencing (NGS) in Drug Discovery & Designing
Figure 13. Global Clinical Next Generation Sequencing (NGS) Market: Drug Discovery & Designing (2018-2023) & ($ Millions)
Figure 14. Clinical Next Generation Sequencing (NGS) in Medical Research
Figure 15. Global Clinical Next Generation Sequencing (NGS) Market: Medical Research (2018-2023) & ($ Millions)
Figure 16. Clinical Next Generation Sequencing (NGS) in Others
Figure 17. Global Clinical Next Generation Sequencing (NGS) Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application in 2022
Figure 19. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Player in 2022
Figure 20. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 22. APAC Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 23. Europe Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure 25. Americas Clinical Next Generation Sequencing (NGS) Value Market Share by Country in 2022
Figure 26. United States Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region in 2022
Figure 31. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type in 2022
Figure 32. APAC Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application in 2022
Figure 33. China Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Country in 2022
Figure 40. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Figure 41. Europe Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Figure 42. Germany Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Clinical Next Generation Sequencing (NGS) Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 56. APAC Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 57. Europe Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 59. United States Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 60. Canada Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 63. China Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 64. Japan Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 65. Korea Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 67. India Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 68. Australia Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 69. Germany Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 70. France Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 71. UK Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 72. Italy Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 73. Russia Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 74. Spain Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 77. Israel Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Clinical Next Generation Sequencing (NGS) Market Size 2024-2029 ($ Millions)
Figure 80. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Clinical Next Generation Sequencing (NGS) Market Size Market Share Forecast by Application (2024-2029)
